{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:52:27Z","timestamp":1792093947875,"version":"4.4.0"},"reference-count":136,"publisher":"Portland Press Ltd.","issue":"2","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":2949,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,15]]},"abstract":"<jats:p>Inflammation when unchecked is associated with many prevalent disorders such as the classic inflammatory diseases arthritis and periodontal disease, as well as the more recent additions that include diabetes and cardiovascular maladies. Hence mechanisms to curtail the inflammatory response and promote catabasis are of immense interest. In recent years, evidence has prompted a paradigm shift whereby the resolution of acute inflammation is a biochemically active process regulated in part by endogenous PUFA (polyunsaturated fatty acid)-derived autacoids. Among these are a novel genus of SPMs (specialized proresolving mediators) that comprise novel families of mediators including lipoxins, resolvins, protectins and maresins. SPMs have distinct structures and act via specific G-protein seven transmembrane receptors that signal intracellular events on selective cellular targets activating proresolving programmes while countering pro-inflammatory signals. An appreciation of these endogenous pathways and mediators that control timely resolution opened a new terrain for therapeutic approaches targeted at stimulating resolution of local inflammation. In the present review, we provide an overview of the biosynthesis and actions of resolvin E1, underscoring its protective role in vascular systems and regulating platelet responses. We also give an overview of newly described resolution circuitry whereby resolvins govern miRNAs (microRNAs), and transcription factors that counter-regulate pro-inflammatory chemokines, cytokines and lipid mediators.<\/jats:p>","DOI":"10.1042\/bj20110327","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T08:23:05Z","timestamp":1309335785000},"page":"185-197","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution"],"prefix":"10.1042","volume":"437","author":[{"given":"Gabrielle","family":"Fredman","sequence":"first","affiliation":[{"name":"Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Harvard Institutes of Medicine and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles\u00a0N.","family":"Serhan","sequence":"additional","affiliation":[{"name":"Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Harvard Institutes of Medicine and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"2021112214482497600_B1","volume-title":"Robbins and Cotran Pathologic Basis of Disease","author":"Kumar","year":"2005"},{"key":"2021112214482497600_B2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrrheum.2009.28","article-title":"Periodontitis in systemic rheumatic diseases","volume":"5","author":"de\u00a0Pablo","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"2021112214482497600_B3","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"2021112214482497600_B4","first-page":"77","article-title":"Platelets: their role in hemostasis, thrombosis, and inflammation","volume-title":"Inflammation: Basic Principles and Clinical Correlates","author":"Marcus","year":"1999"},{"key":"2021112214482497600_B5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0192-0561(00)00064-3","article-title":"Resolution of inflammation","volume":"22","author":"Willoughby","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"key":"2021112214482497600_B6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2021112214482497600_B7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: an update","volume":"1801","author":"Bannenberg","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112214482497600_B8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ. Res."},{"key":"2021112214482497600_B9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2021112214482497600_B10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.plefa.2005.07.001","article-title":"Special issue on lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukotrienes Essent","volume":"73","author":"Serhan","year":"2005","journal-title":"Fatty Acids"},{"key":"2021112214482497600_B11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"key":"2021112214482497600_B12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"2021112214482497600_B13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"2021112214482497600_B14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"2021112214482497600_B15","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J. Immunol."},{"key":"2021112214482497600_B17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"key":"2021112214482497600_B18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2021112214482497600_B19","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1096\/fj.07-8473com","article-title":"Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution","volume":"21","author":"Campbell","year":"2007","journal-title":"FASEB J."},{"key":"2021112214482497600_B20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ni1392","article-title":"Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression","volume":"7","author":"Ariel","year":"2006","journal-title":"Nat. Immunol."},{"key":"2021112214482497600_B21","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol."},{"key":"2021112214482497600_B22","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B23","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.4049\/jimmunol.181.12.8688","article-title":"Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes","volume":"181","author":"Starosta","year":"2008","journal-title":"J. Immunol."},{"key":"2021112214482497600_B24","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for pro-resolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature08029","article-title":"Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors","volume":"459","author":"Riviere","year":"2009","journal-title":"Nature"},{"key":"2021112214482497600_B26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2021112214482497600_B27","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.4049\/jimmunol.181.12.8677","article-title":"Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution","volume":"181","author":"Kasuga","year":"2008","journal-title":"J. Immunol."},{"key":"2021112214482497600_B28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00024382-199411000-00001","article-title":"Mechanisms of endothelial cell injury in acute inflammation","volume":"2","author":"Varani","year":"1994","journal-title":"Shock"},{"key":"2021112214482497600_B29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s000110050208","article-title":"Tissue injury in neutrophilic inflammation","volume":"46","author":"Dallegri","year":"1997","journal-title":"Inflammation Res."},{"key":"2021112214482497600_B30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"2021112214482497600_B31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ni1274","article-title":"Limiting inflammatory responses during activation of innate immunity","volume":"6","author":"Han","year":"2005","journal-title":"Nat. Immunol."},{"key":"2021112214482497600_B32","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ajcn\/79.6.935","article-title":"Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms","volume":"79","author":"Larsson","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"2021112214482497600_B33","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3945\/jn.108.096016","article-title":"Docosahexaenoic acid and the aging brain","volume":"138","author":"Lukiw","year":"2008","journal-title":"J. Nutr."},{"key":"2021112214482497600_B34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico","year":"1999","journal-title":"Lancet"},{"key":"2021112214482497600_B35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.279.1.23","article-title":"Fish consumption and risk of sudden cardiac death","volume":"279","author":"Albert","year":"1998","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021112214482497600_B36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa012918","article-title":"Blood levels of long-chain n-3 fatty acids and the risk of sudden death","volume":"346","author":"Albert","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"2021112214482497600_B37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The omega-3 index: a new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev. Med."},{"key":"2021112214482497600_B38","doi-asserted-by":"crossref","first-page":"a2931","DOI":"10.1136\/bmj.a2931","article-title":"Effect of fish oil on arrhythmias and mortality: systematic review","volume":"337","author":"Leon","year":"2008","journal-title":"BMJ"},{"key":"2021112214482497600_B39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(71)91658-8","article-title":"Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos","volume":"1","author":"Bang","year":"1971","journal-title":"Lancet"},{"key":"2021112214482497600_B40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0954-6820.1976.tb08198.x","article-title":"The composition of food consumed by Greenland Eskimos","volume":"200","author":"Bang","year":"1976","journal-title":"Acta Med. Scand."},{"key":"2021112214482497600_B41","first-page":"227","article-title":"Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family","volume":"8","author":"Dyerberg","year":"1979","journal-title":"Haemostasis"},{"key":"2021112214482497600_B42","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/ajcn\/33.12.2657","article-title":"The composition of the Eskimo food in north western Greenland","volume":"33","author":"Bang","year":"1980","journal-title":"Am. J. Clin. Nutr."},{"key":"2021112214482497600_B43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(79)91490-9","article-title":"Haemostatic function and platelet polyunsaturated fatty acids in Eskimos","volume":"2","author":"Dyerberg","year":"1979","journal-title":"Lancet"},{"key":"2021112214482497600_B44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(78)91505-2","article-title":"Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?","volume":"2","author":"Dyerberg","year":"1978","journal-title":"Lancet"},{"key":"2021112214482497600_B45","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/261558a0","article-title":"Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides","volume":"261","author":"Needleman","year":"1976","journal-title":"Nature"},{"key":"2021112214482497600_B46","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ajcn\/54.3.438","article-title":"Omega-3 fatty acids in health and disease and in growth and development","volume":"54","author":"Simopoulos","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"2021112214482497600_B48","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.76.2.944","article-title":"Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties","volume":"76","author":"Needleman","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0163-7827(81)90073-4","article-title":"Fatty acids as sources of potential \u2018magic bullets\u2019 for the modification of platelet and vascular function","volume":"20","author":"Needleman","year":"1981","journal-title":"Prog. Lipid Res."},{"key":"2021112214482497600_B50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.945611","article-title":"Thromboxanes: selective biosynthesis and distinct biological properties","volume":"193","author":"Needleman","year":"1976","journal-title":"Science"},{"key":"2021112214482497600_B51","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"2021112214482497600_B52","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"2021112214482497600_B53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0091-6749(76)90181-0","article-title":"The mode of action of aspirin and similar compounds","volume":"58","author":"Vane","year":"1976","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021112214482497600_B54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb. Res."},{"key":"2021112214482497600_B55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat. Med."},{"key":"2021112214482497600_B56","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B57","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/01.ATV.0000196729.98651.bf","article-title":"Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial","volume":"26","author":"Chiang","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021112214482497600_B58","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"Morris","year":"2009","journal-title":"J. Immunol."},{"key":"2021112214482497600_B59","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1073\/pnas.1000373107","article-title":"Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways","volume":"107","author":"Morris","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B60","first-page":"643","article-title":"Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions","volume":"51","author":"Serhan","year":"2000","journal-title":"J. Physiol. Pharmacol."},{"key":"2021112214482497600_B61","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1371\/journal.pone.0001316","article-title":"Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator Resolvin E1","volume":"2","author":"Haas-Stapleton","year":"2007","journal-title":"PLoS ONE"},{"key":"2021112214482497600_B62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1096\/fj.05-4724fje","article-title":"RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis","volume":"20","author":"Hasturk","year":"2006","journal-title":"FASEB J."},{"key":"2021112214482497600_B63","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.179.10.7021","article-title":"Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo","volume":"179","author":"Hasturk","year":"2007","journal-title":"J. Immunol."},{"key":"2021112214482497600_B64","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2010.0019","article-title":"Resolvin e1 improves tear production and decreases inflammation in a dry eye mouse model","volume":"26","author":"Li","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"2021112214482497600_B66","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood-2007-11-122598","article-title":"Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets","volume":"112","author":"Dona","year":"2008","journal-title":"Blood."},{"key":"2021112214482497600_B67","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V76.10.1903.1903","article-title":"Stratton lecture 1989. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism","volume":"76","author":"Marcus","year":"1990","journal-title":"Blood"},{"key":"2021112214482497600_B68","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2021112214482497600_B69","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198604103141501","article-title":"In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis","volume":"314","author":"Knapp","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"2021112214482497600_B70","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1016\/j.febslet.2009.10.004","article-title":"Full characterization of PDX, a neuroprotectin\/protectin D1 isomer, which inhibits blood platelet aggregation","volume":"583","author":"Chen","year":"2009","journal-title":"FEBS Lett."},{"key":"2021112214482497600_B71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1096\/fj.10-161836","article-title":"Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation","volume":"25","author":"Chen","year":"2011","journal-title":"FASEB J."},{"key":"2021112214482497600_B72","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/ATVBAHA.110.209908","article-title":"Resolvin E1 regulates adenosine diphosphate activation of human platelets","volume":"30","author":"Fredman","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021112214482497600_B73","volume-title":"Platelets","author":"Michelson","year":"2007"},{"key":"2021112214482497600_B74","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb. Haemost."},{"key":"2021112214482497600_B75","doi-asserted-by":"crossref","DOI":"10.1142\/p513","volume-title":"Platelets in cardiovascular disease","author":"Bhatt","year":"2008"},{"key":"2021112214482497600_B76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","article-title":"Antiplatelet therapies for the treatment of cardiovascular disease","volume":"9","author":"Michelson","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2021112214482497600_B77","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"2021112214482497600_B78","doi-asserted-by":"crossref","first-page":"H1132","DOI":"10.1152\/ajpheart.00079.2008","article-title":"C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta","volume":"295","author":"Ho","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021112214482497600_B79","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2021112214482497600_B80","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM199711063371906","article-title":"Shattuck lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities","volume":"337","author":"Braunwald","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"2021112214482497600_B81","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"2021112214482497600_B82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"2021112214482497600_B83","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.109.199570","article-title":"Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob\/ob mice and reversal by a fish oil diet","volume":"105","author":"Li","year":"2009","journal-title":"Circ. Res."},{"key":"2021112214482497600_B84","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J."},{"key":"2021112214482497600_B85","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI119029","article-title":"Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development","volume":"98","author":"Shen","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2021112214482497600_B86","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M410638200","article-title":"A role for the mouse 12\/15-lipoxygenase pathway in promoting epithelial wound healing and host defense","volume":"280","author":"Gronert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B87","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4049\/jimmunol.0900327","article-title":"12\/15-lipoxygenase counteracts inflammation and tissue damage in arthritis","volume":"183","author":"Kronke","year":"2009","journal-title":"J. Immunol."},{"key":"2021112214482497600_B88","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2353\/ajpath.2010.090678","article-title":"Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury","volume":"176","author":"Leedom","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2021112214482497600_B89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.183.1.137","article-title":"Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction","volume":"183","author":"Maddox","year":"1996","journal-title":"J. Exp. Med."},{"key":"2021112214482497600_B90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-5793(96)01370-1","article-title":"Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase","volume":"399","author":"Alessi","year":"1996","journal-title":"FEBS Lett."},{"key":"2021112214482497600_B91","first-page":"5716","article-title":"Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin","volume":"63","author":"Ly","year":"2003","journal-title":"Cancer Res."},{"key":"2021112214482497600_B92","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","article-title":"Resolvin E1 metabolome in local inactivation during inflammation-resolution","volume":"180","author":"Hong","year":"2008","journal-title":"J. Immunol."},{"key":"2021112214482497600_B93","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7643-7506-5","volume-title":"The Resolution of Inflammation","author":"Rossi","year":"2008"},{"key":"2021112214482497600_B94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","article-title":"Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation","volume":"49","author":"Shimizu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2021112214482497600_B95","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","article-title":"MicroRNAs in cancer: small molecules with a huge impact","volume":"27","author":"Iorio","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"2021112214482497600_B96","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"2021112214482497600_B97","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"2021112214482497600_B98","doi-asserted-by":"crossref","first-page":"iii50","DOI":"10.1136\/ard.2008.100289","article-title":"Adding fuel to fire: microRNAs as a new class of mediators of inflammation","volume":"67","author":"Sheedy","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"2021112214482497600_B99","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1096\/fj.10-169599","article-title":"MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits","volume":"25","author":"Recchiuti","year":"2010","journal-title":"FASEB J."},{"key":"2021112214482497600_B100","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimerStereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni.1828","article-title":"Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21","volume":"11","author":"Sheedy","year":"2009","journal-title":"Nat. Immunol."},{"key":"2021112214482497600_B102","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9258(20)78281-5","article-title":"A new deficiency disease produced by the rigid exclusion of fat from the diet","volume":"82","author":"Burr","year":"1929","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B103","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues","volume":"101","author":"Takano","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2021112214482497600_B104","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.96.14.8247","article-title":"Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo","volume":"96","author":"Clish","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B105","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.4049\/jimmunol.171.12.6856","article-title":"Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators","volume":"171","author":"Serhan","year":"2003","journal-title":"J. Immunol."},{"key":"2021112214482497600_B106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-0193-0_35","article-title":"Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins","volume":"507","author":"Gewirtz","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021112214482497600_B107","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4)","volume":"8","author":"Levy","year":"2002","journal-title":"Nat. Med."},{"key":"2021112214482497600_B108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat. Immunol."},{"key":"2021112214482497600_B109","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI7016","article-title":"Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion","volume":"104","author":"Chiang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2021112214482497600_B110","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1073\/pnas.94.18.9967","article-title":"Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin","volume":"94","author":"Scalia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214482497600_B111","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/jpet.300.2.385","article-title":"Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4)","volume":"300","author":"Fierro","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021112214482497600_B112","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1096\/fj.04-2565com","article-title":"A synthetic eicosanoid LX-mimetic unravels host\u2013donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils","volume":"19","author":"Devchand","year":"2005","journal-title":"FASEB J."},{"key":"2021112214482497600_B113","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ki.1995.184","article-title":"Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis","volume":"47","author":"Papayianni","year":"1995","journal-title":"Kidney Int."},{"key":"2021112214482497600_B114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20061826","article-title":"Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing","volume":"204","author":"Svensson","year":"2007","journal-title":"J. Exp. Med."},{"key":"2021112214482497600_B115","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.164.2.1029","article-title":"Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia","volume":"164","author":"Bandeira-Melo","year":"2000","journal-title":"J. Immunol."},{"key":"2021112214482497600_B116","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1535-7163.MCT-10-0173","article-title":"Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis","volume":"9","author":"Chen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"2021112214482497600_B117","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2010.09.002","article-title":"The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukotrienes Essent","volume":"84","author":"Levy","year":"2011","journal-title":"Fatty Acids"},{"key":"2021112214482497600_B118","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1476-5381.2010.00950.x","article-title":"Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects","volume":"161","author":"Conte","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"2021112214482497600_B119","first-page":"211","article-title":"The protective effects of Lipoxin A(4) during the early phase of severe acute pancreatitis in ratsScand","volume":"46","author":"Zhou","year":"2011","journal-title":"J. Gastroenterol."},{"key":"2021112214482497600_B120","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Med."},{"key":"2021112214482497600_B121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ibd.21029","article-title":"Resolvin E1, an endogenous lipid derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis","volume":"16","author":"Ishida","year":"2010","journal-title":"Inflammatory Bowel Dis."},{"key":"2021112214482497600_B122","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation","volume":"9","author":"Haworth","year":"2008","journal-title":"Nat. Immunol."},{"key":"2021112214482497600_B123","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbrc.2010.08.025","article-title":"Protective effect of resolvin E1 on the development of asthmatic airway inflammation","volume":"400","author":"Aoki","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112214482497600_B124","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2008.01.012","article-title":"Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma","volume":"367","author":"Aoki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112214482497600_B125","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.08-125674","article-title":"Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins","volume":"23","author":"Gonz\u00e1lez-P\u00e9riz","year":"2009","journal-title":"FASEB J."},{"key":"2021112214482497600_B126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat. Med."},{"key":"2021112214482497600_B127","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","article-title":"Resolvin E1 protects the rat heart against reperfusion injury","volume":"299","author":"Keyes","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021112214482497600_B128","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","article-title":"Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin e1","volume":"186","author":"Rajasagi","year":"2011","journal-title":"J. Immunol."},{"key":"2021112214482497600_B129","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury","volume":"177","author":"Duffield","year":"2006","journal-title":"J. Immunol."},{"key":"2021112214482497600_B130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pain.2010.11.021","article-title":"Enduring prevention and transient reduction of post-operative pain by intrathecal resolvin D1","volume":"152","author":"Huang","year":"2011","journal-title":"Pain"},{"key":"2021112214482497600_B131","doi-asserted-by":"crossref","first-page":"43079","DOI":"10.1074\/jbc.M509796200","article-title":"The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering","volume":"280","author":"Ariel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B132","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J. Immunol."},{"key":"2021112214482497600_B133","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia\u2013reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112214482497600_B134","doi-asserted-by":"crossref","first-page":"e15816","DOI":"10.1371\/journal.pone.0015816","article-title":"Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase and PPARgamma-mediated mechanisms in Alzheimer's disease models","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS ONE"},{"key":"2021112214482497600_B135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"2021112214482497600_B136","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/437\/2\/185\/668558\/bj4370185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/437\/2\/185\/668558\/bj4370185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T14:16:45Z","timestamp":1637590605000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/437\/2\/185\/45554\/Specialized-proresolving-mediator-targets-for-RvE1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20110327","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}